dr. cohen discusses entrectinib in head and neck cancer
Published 6 years ago • 149 plays • Length 2:08Download video MP4
Download video MP3
Similar videos
-
1:46
dr. cohen discusses research questions in head and neck cancer
-
1:15
dr. cohen on mtor inhibition in head and neck cancer
-
1:59
dr. cohen discusses immunotherapy combinations in head and neck cancer
-
1:59
dr. cohen discusses nk-directed therapy in head and neck cancer
-
1:06
dr. cohen discusses the keynote-040 trial in head and neck cancer
-
2:05
dr. cohen discusses head and neck cancer pathways
-
1:32
dr. cohen on immunotherapy combinations in head and neck cancer
-
1:36
dr. cohen on immunotherapeutic advances in head and neck cancer
-
2:08
dr. cohen discusses immunotherapy in head and neck cancer
-
2:07
dr. cohen on challenges with immunotherapy in head and neck cancer
-
1:33
dr. cohen on the era before immunotherapy in head and neck cancer
-
0:55
dr. cohen on immunotherapy in head and neck squamous cell carcinoma
-
1:37
dr. cohen on the value of pfs as an endpoint in head and neck cancer
-
4:03
keynote-040: groundbreaking results for pembrolizumab in head and neck cancer
-
2:42
dr. cohen on the rationale of the active8 study in scchn
-
4:45
entrectinib–selective ros inhibition
-
34:46
head and neck cancer immunotherapy: progress in treatment, with ezra cohen
-
4:29
the role of induction chemotherapy in hnscc
-
4:27
entrectinib: a review in ntrk solid tumours and ros1 nsclc